On Invalid Date, Akari Therapeutics (NASDAQ: AKTX) reported Q4 2022 earnings per share (EPS) of N/A, up N/A year over year. Total Akari Therapeutics earnings for the quarter were N/A. In the same quarter last year, Akari Therapeutics's earnings per share (EPS) was $0.00.
As of Q3 2023, Akari Therapeutics's earnings has grown year over year. Akari Therapeutics's earnings in the past year totalled -$17.75 million.
What is AKTX's earnings date?
Akari Therapeutics's earnings date is Invalid Date. Add AKTX to your watchlist to be reminded of AKTX's next earnings announcement.
What was AKTX's revenue last quarter?
On Invalid Date, Akari Therapeutics (NASDAQ: AKTX) reported Q4 2022 revenue of N/A up N/A year over year. In the same quarter last year, Akari Therapeutics's revenue was $0.00.
What was AKTX's revenue growth in the past year?
As of Q3 2023, Akari Therapeutics's revenue has grown null year over year. Akari Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.